Diabetes Discourse

By ReachMD

Science & Medicine Health Medicine

What's Diabetes Discourse about?

The prevalence of type 2 diabetes has increased to more than 8% of the US population, and this growth trend is expected to continue. Advances in diabetes care remain at the forefront of treatment. Diabetes Discourse features the latest developments, from new insulin therapies to exciting research and promising technology.

Download our free app to listen on your phone

LAST EPISODE

Improving Diabetes Care wit...

03.31.2021

Host: Carol Wysham, MD Guest: Irl Hirsch, MD, MACP How is technology like continuous glucose monitors impacting the way we care for patients with diabetes, especially amid the COVID-19 pandemic? To learn more about the technological advancements in diabetes care, ...

Diabetes Discourse episodes:

03.31.2021 Improving Diabetes Care with Technology: A Look at Continuous Glucose Monitors Host: Carol Wysham, MD Guest: Irl Hirsch, MD, MACP How is technology like continuous glucose monitors impacting the way we care for patients with diabetes, especially amid the COVID-19 pandemic? To learn more about the technological advancements in diabetes care, ...
03.31.2021 Discovering the Discordance Between Measured A1Cs & GMIs Host: Carol Wysham, MD Guest: Irl Hirsch, MD, MACP Why was there so much discordance between some patients’ GMI and their measured A1C? That’s the exact question Dr. Irl Hirsch from the University of Washington School of Medicine asked and ...
03.29.2021 Investigating SGLT-2 Inhibitors in Diabetes: Considerations & Conversation Host: John Buse, MD, PhD Guest: Anne Louise Peters, MD SGLT-2 inhibitors have been authorized for diabetic patients in Europe, but is it close to receiving FDA approval in the U.S.? Dr. Anne Peters of USC speaks with Dr. John ...
03.19.2021 A Wake-Up Call to Diabetes: Spreading Awareness of Its Seriousness Host: John Buse, MD, PhD It can be tempting for patients to undermine the seriousness of diabetes. But in recognition of Diabetes Alert Day, Dr. John Buse explains why we need to set the record straight.
03.19.2021 When & How to Screen Patients for Diabetes Host: John Buse, MD, PhD How early should we start screening for diabetes, and what tools are available to us? In recognition of Diabetes Alert Day, Dr. John Buse reviews the current screening tests and recommendations for those who are ...
03.09.2021 Exploring Stem Cell Research & Novel Options in Type 1 Diabetes Host: John E. Anderson, MD Guest: Matthias Hebrok, PhD Emerging research may offer clinicians an alternative approach to treating type 1 diabetes. Dr. John Anderson meets with Dr. Matthias Hebrok, a professor in diabetes research and director of the Diabetes ...
03.05.2021 Investigating Type 1 Diabetes & Its Chronic Impacts Host: John E. Anderson, MD Guest: Matthias Hebrok, PhD What are the effects of type 1 diabetes on the body? Dr. Matthias Hebrok, a professor in diabetes research and director of the Diabetes Center at the University of California, San ...
03.05.2021 Diving into Diabetes: Investigating SGLT2 Inhibitors & Diabetic Ketoacidosis Host: John Buse, MD, PhD Guest: Antonios Douros, MD Dr. John Buse joins Dr. Antonios Douros, Assistant Professor in the Department of Medicine at McGill University and research investigator at Lady Davis Institute in Montreal, Quebec, to discuss his latest ...
03.03.2021 Managing Diabetes During the COVID-19 Pandemic Host: Carol Wysham, MD Guest: Alexis Markey McKee, MD Patient care has evolved amid the COVID-19 pandemic, causing unexpected challenges in managing diseases such as diabetes. Dr. Carol Wysham joins Dr. Alexis McKee, a practicing endocrinologist and an assistant professor ...
02.23.2021 Understanding Dapagliflozin: Examining Its Use in Chronic Kidney Disease Host: John Buse, MD, PhD Guest: David Wheeler, MB, CHB, MD, FRCP Recent research has revealed that a type 2 diabetes treatment may help manage chronic kidney disease. Dr. John Buse discusses the use of dapagliflozin in patients with chronic ...
02.19.2021 Assessing Atypical Diabetes: Detection & Diagnosis Host: Carol Wysham, MD Guest: Janet B. McGill, MD, MA, FACE, FACP Many patients with diabetes don’t fit into our stereotypes of type 1 or type 2 diabetes and identifying them is key to understanding how to treat them. Dr. ...
01.21.2021 Highlighting a Hero in Endocrinology: Dr. Jason Sloane Host: John E. Anderson, MD Guest: Jason Sloane, MD There’s no denying that the COVID-19 pandemic has impacted every aspect of healthcare. So in an effort to recognize those who’ve gone above and beyond the call of duty, ReachMD’s Heroes ...
01.18.2021 Fad Diets & Patients with Type 2 Diabetes Host: John E. Anderson, MD Host: John Buse, MD, PhD Host: Carol Wysham, MD The guidelines for healthy eating encourage a balance of many things, but doesn’t address the specific amount of carbohydrates, protein, and fat. And with so many ...
12.22.2020 Cardio Considerations: Individualized Exercise for Patients with Type 2 Diabetes Host: John E. Anderson, MD Host: John Buse, MD, PhD Host: Carol Wysham, MD Physical activity is a valuable tool in treating patients with type 2 diabetes. But there are several factors clinicians must consider before prescribing exercise, including patient ...
12.22.2020 Prescribing Exercise for Patients with Type 2 Diabetes Host: John E. Anderson, MD Host: John Buse, MD, PhD Host: Carol Wysham, MD Exercise is an essential part of maintaining a healthy lifestyle, especially when managing a chronic condition such as type 2 diabetes. But what should we take ...
12.21.2020 Dietary Decisions for Patients with Type 2 Diabetes Host: John E. Anderson, MD Host: John Buse, MD, PhD Host: Carol Wysham, MD Dietary decisions play a critical supporting role in the treatment of patients with type 2 diabetes. What kind of impact do these nutritional interventions have? Dr. ...
12.16.2020 Facing Formidable Diabetic Cases with Patient Persistence & Adherence Host: John E. Anderson, MD Host: John Buse, MD, PhD Host: Carol Wysham, MD Adhering to treatment can be challenging for many patients with diabetes. Especially for patients on bolus insulin, how can we encourage them to stick to treatment? ...
12.16.2020 Difficulty with Diabetes: Strategies to Overcome Challenging Cases Host: John E. Anderson, MD Host: John Buse, MD, PhD Host: Carol Wysham, MD Diabetic care looks different for every patient. And with so many different variables, challenging cases can become even more challenging to manage. What can endocrinologists do ...
12.09.2020 Managing Diabetes & COVID-19 in the Wintertime Host: John E. Anderson, MD Host: John Buse, MD, PhD Host: Carol Wysham, MD The wintertime presents new challenges for patients with chronic diseases, specifically diabetes. But with the spread of COVID-19, how can we help keep our patients safe ...
11.09.2020 Caring for Diabetic Patients During the COVID-19 Pandemic Host: John E. Anderson, MD Host: John Buse, MD, PhD Host: Carol Wysham, MD The outbreak of the COVID-19 pandemic has pushed healthcare professionals to adjust the way they treat patients with chronic conditions like diabetes. Tune in to hear ...
09.15.2019 Diabetic Retinopathy: Understanding the Impact on Patient Lives and the Need for Timely Diagnosis and Referral Host: Janine Austin Clayton, MD Guest: A. Paul Chous, MA, OD, FAAO, CDE Guest: Anne Peters, MD Guest: Charles Wykoff, MD, PhD Even though diabetic retinopathy is the leading cause of blindness among U.S. adults, a substantial number of patients ...
09.15.2019 In Plain Sight: Evaluating All Patients with Diabetes for Diabetic Retinopathy Host: Janine Austin Clayton, MD Guest: A. Paul Chous, MA, OD, FAAO, CDE Guest: Anne Peters, MD When it comes to protecting the vision of our patients with diabetes, the importance of taking assertive action cannot be ignored. But another ...
09.15.2019 On the Frontline of Diabetic Retinopathy: Assessment of High-Risk Patient Populations Host: Anne Peters, MD Guest: Thomas W. Gardner, MD, MS Guest: Diana Shechtman, OD, FAAO Unfortunately, there are many factors that can contribute to a patient’s risk for vision-threatening complications and vision loss due to diabetes. Explore those factors with ...
09.15.2019 Diabetic Retinopathy: Understanding the Impact on Patient Lives and the Need for Timely Diagnosis and Referral Host: Janine Austin Clayton, MD Guest: A. Paul Chous, MA, OD, FAAO, CDE Guest: Anne Peters, MD Guest: Charles Wykoff, MD, PhD Even though diabetic retinopathy is the leading cause of blindness among U.S. adults, a substantial number of patients ...
09.15.2019 On the Frontline of Diabetic Retinopathy: Assessment of High-Risk Patient Populations Host: Anne Peters, MD Guest: Thomas W. Gardner, MD, MS Guest: Diana Shechtman, OD, FAAO Unfortunately, there are many factors that can contribute to a patient’s risk for vision-threatening complications and vision loss due to diabetes. Explore those factors with ...
09.15.2019 A Call to Action from Regina Benjamin, MD, the 18th U.S. Surgeon General Guest: Regina Benjamin, MD, MS As healthcare providers, it’s our duty to emphasize the importance of preventing the eye-health consequences associated with diabetes, particularly as it pertains to health disparities and underserved populations. This activity featuring Dr. Regina Benjamin serves ...
09.15.2019 In Plain Sight: Evaluating All Patients with Diabetes for Diabetic Retinopathy Host: Janine Austin Clayton, MD Guest: A. Paul Chous, MA, OD, FAAO, CDE Guest: Anne Peters, MD When it comes to protecting the vision of our patients with diabetes, the importance of taking assertive action cannot be ignored. But another ...
08.27.2019 Diabetes Cardiovascular Outcomes Trials: What You Need to Know Guest: Michael H. Davidson, MD Tune in as Dr. Michael Davidson, a preventive cardiologist from the University of Chicago Pritzker School of Medicine, outlines what a diabetes cardiovascular outcomes trial (CVOT) is, the differences between CVOTs and glycemic efficacy trials, ...
02.26.2019 Role of the Cardiologist in T2D Management Host: Jennifer Caudle, DO Guest: Christie Ballantyne, MD With the number of patients with both type 2 diabetes and established cardiovascular disease on the rise, a personalized patient approach to treating these two conditions is now more important than ever. ...
02.12.2019 Care Collaboration: Patients with Type 2 Diabetes & Established Cardiovascular Disease – The Cardiologists' Perspective Host: Jennifer Caudle, DO Guest: Mikhail Kosiborod, MD Guest: Christie Ballantyne, MD Since type 2 diabetes and cardiovascular disease often go hand in hand, having a care collaboration plan in place is essential in managing these conditions. Here to discuss ...
10.15.2018 When Insulin Isn’t Enough: Exploring Dual SGLT1 and SGLT2 Inhibition in T1DM Host: Shira Johnson, MD Guest: Anne Peters, MD Guest: Donna Miller, MSN, FNP-C, CDE Guest: Jana Conley This activity explores new and emerging treatments for type 1 diabetes, including a dual sodium glucose transporter 1/2 inhibitor, and provides both clinician ...
09.25.2018 The P4 Approach: Revolutionizing Diabetic Macular Edema Host: Rishi P. Singh, MD Guest: Arshad Khanani, MD Guest: Ehud Ur, MD Guest: David Boyer, MD Therapeutic options for the treatment of DR and DME have expanded, and advancements in medical imaging technologies provide a wider scope of options ...
09.25.2018 The P4 Approach: Predictive, Preventive, Personalized and Participatory Medicine Host: Rishi P. Singh, MD Guest: Arshad Khanani, MD Guest: Ehud Ur, MD Guest: David Boyer, MD Therapeutic options for the treatment of DR and DME have expanded, and advancements in medical imaging technologies provide a wider scope of options ...
02.28.2018 Diabetes and Cardiovascular Risk: New Thinking, New Opportunities Host: John J. Russell, MD Guest: John (Jack) L. Leahy, MD Diabetes is a major global health emergency, affecting approximately 415 million adults and contributing to five million deaths each year. Cardiovascular disease is a serious complication of type 2 ...
01.23.2018 Improving Glycemic Control: Reducing Patient Burden, The Rationale for Concentrated Insulins in Type 2 Diabetes Mellitus Host: John J. Russell, MD Guest: Anne Peters, MD, CDE Many patients with type 2 diabetes mellitus cannot be controlled with standard insulin agents due to obesity, insulin resistance, high risk of hypoglycemia, low adherence due to high injection burden, ...
01.23.2018 Improving Glycemic Control: Reducing Patient Burden, The Rationale for Concentrated Insulins in Type 2 Diabetes Mellitus Host: John J. Russell, MD Guest: Anne Peters, MD, CDE Many patients with type 2 diabetes mellitus cannot be controlled with standard insulin agents due to obesity, insulin resistance, high risk of hypoglycemia, low adherence due to high injection burden, ...
11.28.2017 Enhancing Adherence to Maintain Glycemic Control in Patients with Type 2 Diabetes Host: Matt T. Rosenberg, MD Guest: Monica E. Peek, MD, MPH, MSC Attaining and maintaining glycemic control continues to be very difficult for patients with type 2 diabetes. Please join Drs. Matt T. Rosenberg and Monica E. Peek as they ...
05.15.2017 How to Administer Fixed-Ratio Combinations of GLP-1 Receptor Agonists & Basal Insulin Host: Matt Birnholz, MD Guest: Javier Morales, MD, FACP, FACE Guest: Wendy S. Lane, MD Demonstration and Panel Discussion: We will present video demonstrations of how to administer fixed-ratio combinations of GLP-1 receptor agonists and basal insulin, accompanied by a ...
05.15.2017 How Fixed-Ratio Combinations Are Individualizing Type 2 Diabetes Treatment Host: Jennifer Caudle, DO Guest: Javier Morales, MD, FACP, FACE In this case-based discussion, Dr. Morales will share insights from his clinical experience on selecting patients likely to benefit from treatment with fixed-ratio combinations of GLP-1 receptor agonists and basal ...
05.15.2017 What is the Rationale for Fixed-Ratio Combinations of Basal Insulin Analogs and GLP-1 Receptor Agonists? Host: John J. Russell, MD Guest: Wendy S. Lane, MD In this interview, Dr. Lane will review the clinical evidence supporting combinations of GLP-1 receptor agonists with basal insulin for the treatment of type 2 diabetes.
12.15.2016 Optimizing Outcomes in Diabetic Retinopathy: Improving Screening, Referral, and Treatment Host: Matt Birnholz, MD Guest: Rishi P. Singh, MD The past 40 years have witnessed great advancements in therapeutic options for treating diabetic retinopathy. Despite a number of effective treatment options, diabetic eye disease is one of the leading causes ...
10.12.2015 Comparing Normal Insulin Physiology and Insulin Dysfunction in Diabetes Mellitus: Constructing Optimal Insulin-Based Regimens Guest: Janet B. McGill, MD, MA, FACE The Centers for Disease Control and Prevention estimates that 9.3% of the US population has diabetes mellitus (DM), and that 27.8% of this population has undiagnosed DM. Patients with DM have twice the ...
08.31.2015 The Role of the Certified Diabetes Educator: A Team Effort Host: John J. Russell, MD Guest: Candis Morello, PharmD, CDE Candis M Morello, Professor of Clinical Pharmacy at UC San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences, joins Dr. John Russell to talk about team-based care integrations of certified ...
08.24.2015 Effective Strategies for the Patient with Poorly Controlled Type 2 Diabetes Host: John J. Russell, MD Guest: Serena Cardillo, MD Host Dr. John Russell welcomes Dr. Serena Cardillo, Associate Professor of Medicine in the Division of Endocrinology, Diabetes, & Metabolism at Penn Medicine. Dr. Cardillo guides listeners through the challenges in ...
08.17.2015 Toward a Healthier Journey for the Type 2 Diabetes Patient Host: John J. Russell, MD Guest: Candis Morello, PharmD, CDE Host Dr. John Russell welcomes Candis M. Morello, PharmD., CDE, FCSHP, Professor of Clinical Pharmacy and Associate Dean for Student Affairs at the Skaggs School of Pharmacy and Pharmaceutical Sciences. ...
08.10.2015 Fostering a "Back to Basics" Model in Type 2 Diabetes Care Host: John J. Russell, MD Guest: Neil Skolnik, MD For clinicians managing patients with T2DM, the clinical landscape for standards of care, diagnostic methods and techniques, and treatment options has become increasingly complex. Yet despite this challenge in keeping up ...
01.28.2013 Anti-inflammatory, Anti-atherogenic and Cardioprotective Effects of Insulin Guest: Paresh Dandona, MD, PhD Host: Farhad Zangeneh, MD Host Dr. Farhad Zangeneh welcomes Paresh Dandona MD, PhD, Professor and Chief of Endocrinology in the Department of Medicine at the University of Buffalo. His Specialty and Research Focus are in ...
01.27.2013 Physiologic Fundamentals of Impaired Glucose Metabolism Guest: Robert A. Rizza, MD Host: Farhad Zangeneh, MD What are the sources of glucose in the body? Is diabetes a pancreatic disease or a hepatic disease? What is the importance of glucose toxicity in Type 1 or Type 2 ...
10.28.2012 Postprandial Blood Glucose: Diabetes Control & Complications Host: Farhad Zangeneh, MD Guest: Paul Jellinger In diabetes management, clinicians typically measure glycemic control with fasting plasma glucose (FPG) and premeal glucose measurements, and HbA1c. And, the goals for each of these measurements have been established based on the ...
10.28.2012 Growing Concerns of Diabetes and Various Cancers Guest: Yehuda Handelsman, MD Host: Farhad Zangeneh, MD Dr Farhad Zangeneh is joined by Dr. Yehuda Handelsman, Medical Director at the Metabolic Institute of America; President of the American Association of Clinical Endocrinologists; and, Chair & Program Director, "Annual World ...

Older episodes